Arsenic Trioxide

mitogen-activated protein kinase kinase 7 ; Homo sapiens







12 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 23548265 Synergistic anticancer activity of arsenic trioxide with erlotinib is based on inhibition of EGFR-mediated DNA double-strand break repair. 2013 Jun 2
2 22293863 MAPK inhibitors and siRNAs differentially affect cell death and ROS levels in arsenic trioxide-treated human pulmonary fibroblast cells. 2012 May 1
3 20592496 Arsenic trioxide inhibits osteosarcoma cell invasiveness via MAPK signaling pathway. 2010 Aug 1 1
4 20615082 Arsenic trioxide cooperates with all trans retinoic acid to enhance mitogen-activated protein kinase activation and differentiation in PML-RARalpha negative human myeloblastic leukemia cells. 2010 Sep 1
5 19428345 Enhancement of esculetin on arsenic trioxide-provoked apoptosis in human leukemia U937 cells. 2009 Jun 15 2
6 19846917 The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels. 2009 Oct 1
7 18583568 Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways. 2008 Sep 15 3
8 16283431 Opposite effect of ERK1/2 and JNK on p53-independent p21WAF1/CIP1 activation involved in the arsenic trioxide-induced human epidermoid carcinoma A431 cellular cytotoxicity. 2006 Jan 2
9 17168655 Arsenic trioxide in hematological malignancies: the new discovery of an ancient drug. 2006 Dec 2
10 15843040 Pharmacological inhibitors of extracellular signal-regulated protein kinases attenuate the apoptotic action of cisplatin in human myeloid leukemia cells via glutathione-independent reduction in intracellular drug accumulation. 2005 Apr 15 1
11 16101455 Beyond single pathway inhibition: MEK inhibitors as a platform for the development of pharmacological combinations with synergistic anti-leukemic effects. 2005 1
12 16445569 Inhibition of mitogen-activated protein kinase kinase enhances apoptosis induced by arsenic trioxide in human breast cancer MCF-7 cells. 2005 Dec 2